Hester is one of India’s leading animal healthcare companies & the second largest poultry vaccine manufacturer in the country. It has a strategic presence in 30+ countries with key markets being India, Nepal and Tanzania.
Numbers were impacted as poultry farm economics turned adverse due to rise in feed costs and decline in end-product prices
Adjusted PAT was at ₹ 7.7 crore (down 41% YoY). [Base of Q4FY21 had ₹ 6.8 crore of license fee income]
Pharmaceuticals company Hester Biosciences announced Q4FY23 & FY23 results:
Standalone Q4FY23 & FY23:
Equity Capital: 259.99 Cr FV: 10.00
| Period | MF Net Purchase / (sold) | FII Net |
|---|---|---|
| LAST 1M | 2,333.12 | 37,369.27 |
| LAST 3M | 16,668.82 | 53,102.69 |
| LAST 6M | 64,410.78 | 32,565.35 |
| LAST 12M | 119,684.93 | 75,969.00 |
| Date | Action Type | Ratio |
|---|---|---|
| Aug 11, 2022 | Dividend | 100 |
| Aug 05, 2021 | Dividend | 100 |
Incorporated as a private limited company in Apr.`87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.`93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company`s own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.
1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006
| Tel | : | 91-079-26445107 |
| : | mail:hester.in | |
| Website | : | http://www.hester.in |
Sharepro Services India Pvt Lt
| AGM Date (Month) | : | Aug |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 524669 |
| NSE Code | : | HESTERBIO |
| Book Closure Date (Month) | : | Aug |
| BSE Group | : | A |
| ISIN | : | INE782E01017 |
FAQ’s on Hester Biosciences Ltd SharesYou can buy Hester Biosciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Hester Biosciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 31, 2023 03:57 PM the closing price of Hester Biosciences Ltd was ₹ 1,648.65.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 31, 2023 03:57 PM, the market cap of Hester Biosciences Ltd stood at ₹ 1,402.51.
The latest PE ratio of Hester Biosciences Ltd as of May 31, 2023 03:57 PM is 53.04
The latest PB ratio of Hester Biosciences Ltd as of May 31, 2023 03:57 PM is 0.20
The 52-week high of Hester Biosciences Ltd is ₹ 2,450.00 while the 52-week low is ₹ 1,404.55
According to analyst recommendations, Hester Biosciences Ltd has a “Buy” rating for the long term.
Download Our App
Invest
